Design Highlights
- Q4 2024 experienced a significant funding drop to $688.24 million, the lowest since Q2 2018, raising sustainability concerns.
- Despite the decline in funding, the number of Insurtech deals slightly increased, indicating a potential shift in market dynamics.
- Property and casualty (P&C) segment faced severe challenges with a 43.5% funding decrease, reflecting instability in this area.
- AI-enabled transactions accounted for 42% of funding in Q4, highlighting growing investor interest in technology-driven solutions over traditional offerings.
- Overall, while 2024 saw a year-over-year funding increase, mixed results and investor caution suggest a shaky outlook moving into 2025.
Insurtech funding has taken a wild ride lately, and not in the direction most were hoping for. The fourth quarter of 2024 has brought some alarming news. Global InsurTech funding plummeted from $1.38 billion in Q3 to a mere $688.24 million. That’s a staggering drop, halving in just three months.
To put things in perspective, this marks the lowest funding level since Q2 2018, when it was just $591.18 million. Ouch.
Interestingly, the number of InsurTech deals didn’t follow suit. It ticked up by one, moving from 77 to 78. So, more deals, but less cash. It’s like throwing a party and having twice as many guests but half the snacks.
More deals, but less cash—it’s like a party with double the guests and half the snacks.
The property and casualty (P&C) segment didn’t fare any better, with funding down a shocking 43.5% to $408.38 million. Not great, right?
But hang on, there’s a twist. A whopping 42% of the funding in Q4 was directed toward AI-enabled transactions. So, while the overall funding is tanking, AI seems to be the shiny new toy everyone wants to play with. This trend reflects lower deal count suggests decreased investor interest and larger round sizes.
It’s almost like InsurTech is saying, “Hey, let’s focus on the future!” while ignoring the present.
Looking at the broader picture, 2024 did see a year-over-year funding increase of 53.6%, totaling $1.66 billion. However, the number of deals took a dive, dropping 18.5% from 422 in 2023 to just 344.
What gives? Early-stage funding and average deal sizes showed some positive trends, but the absence of mega-round deals in Q4 has investors scratching their heads.
As for the early days of 2025, things are still shaky. P&C funding hit rock bottom, the lowest since Q1 2018, while life and health InsurTech funding nearly tripled in Q2. Talk about a mixed bag.
Global funding dropped 16.7% quarter-over-quarter, with average P&C deal sizes plummeting by 66.7%. Insurtech deal count hit 76 in Q3’25, the lowest level since 2016. Investors are fleeing, too. The count of active investors fell from a peak of 655 to just 186. It’s like a ghost town out there!
In the long run, late-stage startups are pulling the most weight, grabbing 60% of insurer investments.
